2023上半年营收增长0.7%,营业利润萎缩17.7%,净利润大幅萎缩72.2%。
目前市盈率17.6,市盈率TTM提高...查看全文
药明康德2019-12-04 12:17
▎医药观澜/报道
12月2日,知名网站GEN发布《2019全球免疫肿瘤学初创公司TOP10》,其中包括未上市的癌症免疫疗法企业,该排名按照企业总募资金额进行排名。值得一提的是,天境生物则以3.798亿美元募资额,成为唯一一家上榜的中国免疫肿瘤学初创公司。我们一起来看看,在即将过去的这一年,这1...查看全文
$SITE Centers(SITC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-24-050190 Act: 34 Size: 6 MB 网页链接
$SITE Centers(SITC)$ 3/A [Amend] Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-045707 Size: 4 KB 网页链接
$SITE Centers(SITC)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-24-084745 Act: 34 Size: 5 MB 网页链接
$SITE Centers(SITC)$ ARS Annual Report to Security Holders Accession Number: 0001193125-24-084757 Act: 34 Size: 562 KB 网页链接
$SITE Centers(SITC)$ 144 Report of proposed sale of securities Accession Number: 0001969223-24-000278 Act: 33 Size: 116 KB 网页链接
$SITE Centers(SITC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000950170-24-031454 Size: 9 KB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-031481 Size: 4 KB 网页链接
$SITE Centers(SITC)$ 8-K Current report, item 5.02 Accession Number: 0001193125-24-066820 Act: 34 Size: 180 KB 网页链接
$SITE Centers(SITC)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-062976 Act: 34 Size: 5 MB 网页链接
$SITE Centers(SITC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027127 Size: 6 KB 网页链接